Atara Biotherapeutics: 3Q Earnings Snapshot

November 6, 2018

SOUTH SAN FRANCISCO, Calif. (AP) _ Atara Biotherapeutics Inc. (ATRA) on Tuesday reported a loss of $58.4 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.29.

The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.18 per share.

Atara Biotherapeutics shares have more than doubled since the beginning of the year. The stock has more than doubled in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA

Update hourly